A Study of Patient Preferences and Drivers of Treatment Satisfaction in Patients With Rosacea
Phase of Trial: Phase IV
Latest Information Update: 18 May 2017
At a glance
- Drugs Azelaic acid (Primary) ; Brimonidine; Metronidazole
- Indications Rosacea
- Focus Therapeutic Use
- Sponsors Bayer
- 19 Jul 2016 Status changed from active, no longer recruiting to completed.
- 11 Feb 2016 Planned number of patients changed from 800 to 200 as reported by ClinicalTrials.gov.
- 11 Feb 2016 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.